CENTRAL DIABETES INSIPIDUS

✓ Medically ReviewedDISEASEID: MDBT0237🚨 TRIAGE: URGENTICD-10: E23.2

📖

Definition

CLINICAL DEFINITION

Central diabetes insipidus (CDI) is a rare endocrine disorder characterised by the deficient synthesis or release of arginine vasopressin (AVP) from the posterior pituitary, leading to an inability to concentrate urine. This results in the passage of large volumes of hypotonic urine (polyuria) and a compensatory increase in fluid intake (polydipsia), provided the thirst mechanism is intact.

IN PLAIN ENGLISH

Central diabetes insipidus is a condition where the brain does not make or release enough of the hormone that tells the kidneys to hold onto water. Because the kidneys cannot retain water, a person produces a very large amount of clear urine and feels extremely thirsty.

COMMON MISCONCEPTION / WHAT IT DOES NOT MEAN

Central diabetes insipidus is NOT diabetes mellitus, which involves high blood sugar and glucose in the urine. It is also NOT nephrogenic diabetes insipidus, where AVP levels are normal or high but the kidneys fail to respond to the hormone.

🔤

Word Breakdown

central

=originating in the central nervous system (hypothalamus or posterior pituitary)

diabetes / insipidus

=diabetes (from Greek 'diabainein' — to pass through) and insipidus (Latin — tasteless, without flavour, distinguishing it from 'mellitus' meaning sweet)

Literal Meaning: A central (brain-related) condition characterised by the passing of large volumes of tasteless (insipid) urine

🏷️

Abbreviations

CDI=Central Diabetes Insipidus — distinguishes from nephrogenic causes

DI=Diabetes Insipidus — general term for polyuric states with dilute urine

ADH=Antidiuretic Hormone — synonymous with arginine vasopressin (AVP)

🔄

Synonyms & Variants

Neurogenic Diabetes Insipidus›Neurohypophyseal Diabetes Insipidus›Vasopressin-Deficient Diabetes Insipidus›

🎯

Category-Specific Context

As a disease, central diabetes insipidus is classified within the broader spectrum of arginine vasopressin (AVP) deficiency disorders. It is distinguished from nephrogenic diabetes insipidus (AVP resistance), gestational diabetes insipidus (vasopressinase excess), and primary polydipsia (suppressed AVP due to excessive fluid intake).

🏥

Clinical Context & Usage

CLINICAL SETTINGS

Endocrinology ClinicNeurosurgery WardIntensive Care UnitEmergency DepartmentGeneral Medicine Ward

USAGE & DOCUMENTATION NOTES

Clinicians typically document 'central DI' or 'CDI' when the aetiology is known to be hypothalamic or pituitary. In post-operative neurosurgery notes, it is often tracked via strict fluid balance charts, urine output targets, and serum sodium trends. Desmopressin (DDAVP) requirements are frequently titrated based on urine output and serum osmolality.

🔬

Primary Causes & Pathophysiology

PATHOPHYSIOLOGY

Arginine vasopressin (AVP) is synthesised in the supraoptic and paraventricular nuclei of the hypothalamus and transported down axons to the posterior pituitary for storage and release. In central diabetes insipidus, damage to the hypothalamus, pituitary stalk, or posterior pituitary impairs AVP synthesis, transport, or secretion. Without adequate circulating AVP, the V2 receptors in the renal collecting ducts are not activated. Consequently, aquaporin-2 water channels are not inserted into the apical membrane of the principal cells, rendering the collecting duct impermeable to water. This leads to the excretion of large volumes of inappropriately dilute urine despite normal or elevated serum osmolality.

PRIMARY CAUSES

Idiopathic / Autoimmune

Autoimmune destruction of AVP-secreting magnocellular neurons, often associated with circulating autoantibodies against vasopressin-secreting cells.

Traumatic Brain Injury (TBI) and Neurosurgery

Physical disruption of the hypothalamic-neurohypophyseal tract during skull base surgery, pituitary adenoma resection, or severe head trauma.

Tumours (Craniopharyngioma, Germinoma, Metastases)

Mass effect or direct infiltration of the hypothalamus or pituitary stalk, compressing or destroying AVP-producing neurons.

Infiltrative Diseases (Langerhans Cell Histiocytosis, Sarcoidosis, IgG4-related disease)

Granulomatous or inflammatory infiltration of the pituitary stalk, leading to thickening and impaired axonal transport of AVP.

Infections (Meningitis, Encephalitis, Tuberculosis)

Direct infectious or post-infectious inflammatory damage to the hypothalamus or posterior pituitary.

Vascular (Internal carotid artery aneurysm, pituitary apoplexy)

Ischaemic necrosis or haemorrhagic infarction of the pituitary gland or hypothalamus, compromising AVP production or transport.

🌍

Epidemiology

Prevalence:Rare; estimated prevalence of 1 in 25,000 to 1 in 100,000 in the general population. Post-pituitary surgery, transient or permanent DI occurs in up to 10–20% of patients depending on the extent of resection.

Age Group:Can occur at any age. Idiopathic and autoimmune forms often present in young adults, while tumours and infiltrative diseases may present in childhood (e.g., Langerhans cell histiocytosis, germinomas) or older adults (metastases).

Sex Predilection:Equal

Geographic Distribution:Globally distributed with no specific regional concentration, though infectious causes (e.g., tuberculosis) may be more prevalent in endemic regions.

Red Flags & Triage ★

TRIAGE LEVEL

🚨 URGENT

DO NOT MISS — LIFE-THREATENING PRESENTATIONS

Adipsic Central Diabetes Insipidus — destruction of the hypothalamic osmoreceptors abolishes thirst. Without strict fluid scheduling, these patients rapidly develop life-threatening hypernatraemia and neurological collapse.
Anterior Pituitary Deficiency — concomitant secondary adrenal insufficiency may mask polyuria (cortisol is required for free water clearance). Initiating glucocorticoids can unmask or worsen DI.

URGENT EVALUATION TRIGGERS

Serum sodium > 150 mmol/L with altered mental status — requires urgent free water replacement and AVP therapy
Polyuria > 3 L/day in a post-operative neurosurgery patient — requires immediate fluid balance review and serum electrolytes
New-onset severe polyuria with impaired consciousness or inability to access free water — medical emergency

Contraindications & Precautions

CONTRAINDICATIONS

Desmopressin is contraindicated in patients with hyponatraemia or a history of water intoxication.
Fluid restriction is contraindicated in untreated CDI
as it will rapidly lead to life-threatening hypernatraemia and hypovolaemia.

SPECIAL PRECAUTIONS

Monitor serum sodium closely when initiating or adjusting desmopressin to avoid iatrogenic hyponatraemia.
In adipsic CDI (impaired thirst)
strict fluid intake prescriptions and daily weight monitoring are required to prevent extreme sodium fluctuations.
Caution with medications that can worsen polyuria or interact with fluid balance (e.g.
lithium
corticosteroids
loop diuretics).

Complications

DOWNSTREAM CLINICAL COMPLICATIONS

Severe Hypernatraemia and Dehydration — occurs if the patient loses access to free water or has an impaired thirst mechanism (adipsic DI)
Hyponatraemia — iatrogenic complication from overtreatment with desmopressin without adequate fluid restriction
Bladder Dysfunction and Hydronephrosis — chronic high urine flow can lead to megacystis
hydroureter
and secondary renal impairment

🔀

Confused With (LASA & DDx) ★

LEXICAL (LASA) — SIMILAR NAMES

Diabetes Mellitus

Shares the word 'diabetes' (meaning polyuria), but DM is characterised by hyperglycaemia and glycosuria, whereas DI involves normal blood glucose and hypotonic urine.

Nephrogenic Diabetes Insipidus

Clinically presents with identical symptoms of polyuria and polydipsia, but the defect is renal resistance to AVP rather than central AVP deficiency.

CLINICAL DIFFERENTIAL DIAGNOSES (DDx)

Primary Polydipsia

Key Distinguishing Feature: Excessive water intake suppresses AVP physiologically. Serum sodium is often low-normal, and urine osmolality increases during a water deprivation test, unlike in CDI.

Nephrogenic Diabetes Insipidus

Key Distinguishing Feature: Kidneys fail to respond to AVP. Exogenous desmopressin administration does not significantly increase urine osmolality, whereas it does in CDI.

Osmotic Diuresis

Key Distinguishing Feature: Polyuria driven by osmotically active solutes (e.g., glucose, urea, mannitol). Urine osmolality is typically >300 mOsm/kg, unlike the dilute urine (<300 mOsm/kg) seen in DI.

💎

Clinical Pearls

💎

Copeptin, a peptide co-secreted with AVP from the posterior pituitary, is a stable surrogate marker for AVP. A stimulated copeptin level > 4.9 pmol/L after hypertonic saline infusion reliably distinguishes primary polydipsia from CDI, largely replacing the traditional water deprivation test.

💎

The 'triple phase' response is classically seen after pituitary stalk section: initial polyuria (axonal shock and DI), followed by antidiuresis (release of pre-formed AVP from degenerating neurons, risking hyponatraemia), and finally permanent DI once AVP stores are depleted.

💎

Desmopressin can be administered orally, intranasally, or parenterally. Intranasal absorption can be erratic if the patient has rhinitis or nasal congestion, making the oral route preferred for chronic maintenance.

💎

Cortisol is required to inhibit AVP secretion and maintain normal free water excretion. Undiagnosed secondary adrenal insufficiency can mask the polyuria of CDI; starting hydrocortisone may abruptly precipitate overt DI.

📝

Example Usage & SOAP

CLINICAL SENTENCE

"The patient developed sudden-onset polyuria of 6 L/day with a serum sodium of 152 mmol/L and urine osmolality of 120 mOsm/kg on post-operative day 2 following transsphenoidal resection of a macroadenoma, consistent with transient central diabetes insipidus."

IN A SOAP NOTE

S: Reports extreme thirst and waking up 5 times overnight to drink water and pass large volumes of clear urine. O: BP 110/70, HR 95. Dry mucous membranes. Serum Na 154 mmol/L, Osm 315 mOsm/kg. Urine Osm 140 mOsm/kg, SG 1.002. A: Central diabetes insipidus, likely secondary to recent neurosurgery. Adipsic features not present. P: Initiate desmopressin 0.1 mg PO. Strict fluid balance chart. Recheck serum Na in 6 hours. Allow free access to water.

DIFFERENTIAL DIAGNOSIS CONTEXT

Differential for polyuria with dilute urine: (1) Central diabetes insipidus — deficient AVP production, responds to exogenous desmopressin; (2) Nephrogenic diabetes insipidus — renal AVP resistance, no response to desmopressin; (3) Primary polydipsia — behavioural or psychogenic excessive water intake, low baseline serum sodium, concentrates urine upon water deprivation.

📈

Prognosis

SHORT-TERM OUTCOME

With appropriate desmopressin replacement and fluid access, symptoms resolve rapidly and serum sodium normalises within 24–48 hours. Post-surgical DI may be transient, resolving within days to weeks.

LONG-TERM PROGNOSIS

Permanent CDI requires lifelong desmopressin therapy. Prognosis is generally excellent and life expectancy is normal, provided the thirst mechanism is intact and the underlying aetiology (e.g., malignancy) does not dictate otherwise.

📚

References & Coding

ICD-10 DIAGNOSTIC CODE

E23.2

LITERATURE CITATIONS & GUIDELINES

[1]Christ-Crain M et al. Diabetes insipidus. Nat Rev Dis Primers. 2019;5(1):54.

[2]Fenske W et al. A copeptin-based approach in the diagnosis of diabetes insipidus. N Engl J Med. 2018;379(5):428-439.

[3]Di Iorgi N et al. Diabetes insipidus--diagnosis and management. Horm Res Paediatr. 2012;77(2):69-84.

MEDICAL DISCLAIMER — This content is intended for educational purposes and qualified healthcare professionals only. Always refer to current clinical diagnostic criteria, institutional protocols, and official guidelines. Medobo is not responsible for clinical decisions made based on this content.